Omnicell (OMCL) announces CFO Etta stepping down

Omnicell, Inc. (NASDAQ: OMCL), a leader in transforming the pharmacy and nursing care delivery model, today announced that Nchacha Etta will be stepping down from his role as Executive Vice President and Chief Financial Officer, effective September 15, 2025 or until a successor is named. Mr. Etta will continue to serve as Executive Vice President and Chief Financial Officer while Omnicell searches for a new Chief Financial Officer and will work to ensure a smooth transition of his role and responsibilities. The Company has commenced a national search for his successor.

“Since joining Omnicell in mid-2023, Nchacha’s insights and contributions have been invaluable as we worked to integrate recent acquisitions, implement operational efficiencies, and navigate challenging industry headwinds,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “On behalf of myself and the Board of Directors, I would like to thank Nchacha for his dedication and wish him all the best in his future endeavors.”

Omnicell today reiterates its first quarter and full year 2025 guidance provided with the Company’s previously issued fiscal year and fourth quarter 2024 earnings release on February 6, 2025.

“As we progress through 2025, we remain focused on successfully executing on our strategic priorities and driving long-term revenue growth while striving to deliver the innovation and expertise that should help our customers achieve enhanced clinical and operational outcomes, as they seek to move closer to the industry-defined vision of the Autonomous Pharmacy,” Mr. Lipps said.

You May Also Be Interested In

• Beneficient CEO confirmed, former chief convicted in fiscal 2026 update
• Tilray Brands acquires HelloMD to expand Canadian cannabis platform
• Activist Jana Partners takes 6.3% stake in Alkami Technology, urges sale